64
K. Khosravi, S. Kazemi / Chinese Chemical Letters 23 (2012) 61–64
conversion of the substrate as indicated by TLC analysis, the reaction mixture was filtrated and then poured onto 50 g
of crushed ice and stirring was continued for few minutes. The solid products were filtered, washed with cold water
(
2 Â 50 mL) and recrystallized from ethanol.
General procedure for the synthesis 2-arylbenzothiazoles in room temperature. To a mixture of 1 mmol of aldehyde
and 1 mmol of 2-aminothiophenol dissolved in 5 ml of MeCN, 0.1 mmol of hexamethylenetetramine–bromine was
added. The mixture was riled at room temperature for proper time. The progress of reaction was monitored by TLC.
After completion of the reaction, the reaction mixture was filtrated and then poured onto 50 g of crushed ice and
stirring was continued for few minutes. The solid products were filtered, washed with cold water (2 Â 50 mL) and
recrystallized from ethanol.
General procedure for the synthesis 2-arylbenzothiazoles in microwave irradiation. A mixture of 2-amino-
thiophenol (0.125 g, 1 mmol) and aldehyde (1 mmol) dissolved in MeCN (10 mL) was added 0.1 mmol of
hexamethylenetetramine–bromine was capped and irradiated in a microwave oven (model: Black & Decker, MX30PG
1
000 W) for the appropriate time (Table 2). The progress of the reaction was monitored by intermittent rapid cooling
of the mixture to r.t. every 1 min and analyzing by TLC (n-hexane/ethyl acetate, 2:8). After complete conversion of the
substrate as indicated by TLC analysis, the reaction mixture was filtrated and then poured onto 50 g of crushed ice and
stirring was continued for few minutes. The solid products were filtered, washed with cold water (2 Â 50 mL) and
recrystallized from ethanol.
1
13
All the products are known compounds which were characterized by their IR, H and C NMR spectral data and
their mps compared with literature reported mps (Tables 1 and 2).
References
[
[
[
[
[
[
[
[
[
1] T. Roth, M.L. Morningstar, P.L. Boyer, et al. J. Med. Chem. 40 (1997) 4199.
2] P.L. Beaulieu, M. Bos, Y. Bousquet, et al. Bioorg. Med. Chem. Lett. 14 (2004) 119.
3] J.L. Falco, M. Pique, M. Gonzalez, et al. Eur. J. Med. Chem. 41 (2006) 985.
4] K. Takkeuchi, J.A. Bastian, D.S. Gifford-Moore, et al. Bioorg. Med. Chem. Lett. 10 (2000) 2347.
5] H. Goker, S. Ozden, S. Yildiz, D.W. Boykin, Eur. J. Med. Chem. 40 (2005) 1062.
6] I.H. Hall, N.J. Peaty, J.R. Henry, et al. Arch. Pharm. 332 (1999) 115.
7] P.J. Palmer, R.B. Trigg, J.V. Warrington, J. Med. Chem. 14 (1971) 248.
8] A. Benazzouz, T. Boraud, P. Dub e´ dat, et al. Eur. J. Pharmacol. 284 (1995) 299.
9] B. Lara, L. Gandia, A. Tores, et al. Eur. J. Pharmacol. 325 (1997) 109.
[10] B.L. Mylari, E.R. Larson, T.A. Beyer, et al. J. Med. Chem. 34 (1991) 108.
[11] G. Sato, T. Chimoto, T. Aoki, et al. J. Toxicol. Sci. 24 (1999) 165.
[12] D.J. Hadjipavlou-Litina, A.A. Geronikaki, Drug Des. Discov. 15 (1997) 199.
[13] R. Paramashivappa, P. Phani Kumar, P.V. Subba Rao, et al. Bioorg. Med. Chem. Lett. 13 (2003) 657.
[14] A.A. Nagel, D.R. Liston, S. Jung, et al. J. Med. Chem. 38 (1995) 1084.
[15] J.H. Matthews, R. Krishnan, M.J. Costanzo, et al. J. Biophys. (1996) 2830.
[16] R.G. Caccese, J.F. DiJoseph, J.S. Scotnicki, et al. Agents Actions 34 (1991) 223.
[17] S.K. Sohn, M.S. Chang, W.S. Choi, et al. Can. J. Physiol. Pharmacol. 77 (1999) 330.
[18] M.F. Surgue, P. Gautheron, C. Schmitt, et al. J. Pharmacol. Exp. Ther. 232 (1985) 534.
[19] C.W. Phoon, P.Y. Ng, A.E. Ting, et al. Bioorg. Med. Chem. Lett. 11 (2001) 1647.
[20] D. Loos, E. Sidoova, V. Sutoris, Molecules 4 (1999) 81 (the references cited therein).
[21] S.K. Ivanov, V.S. Yuritsyn, Neftekhimiya 11 (1971) 99;
S.K. Ivanov, V.S. Yuritsyn, Chem. Abstr. 74 (1971) 124487m.
[22] Monsanto Co. Brit Pat. 1,106,577, 1968.
Chem. Abstr. 68 (1968) 96660t.
[
[
[
[
[
[
23] A.R. Porcari, R.V. Devivar, L.S. Kucera, et al. J. Med. Chem. 41 (1998) 1252.
24] J.G. Smith, I. Ho, Tetrahedron Lett. 12 (1971) 3541.
25] A. Couture, P. Grandclaudon, Heterocycles 22 (1984) 1383.
26] E. Kashiyama, I. Hutchinson, M.S. Chau, et al. J. Med. Chem. 42 (1999) 4172.
27] A. Ben-Alloum, S. Bakkas, M. Soufiaoui, Tetrahedron Lett. 38 (1997) 6395.
28] M.M. Heravi, N. Abdolhosseini, H.A. Oskooie, Tetrahedron Lett. 46 (2005) 8959.